October 13, 2017
Daratumumab darzalex
Patients in Scotland will now be able to access the new myeloma treatment, daratumumab (Darzalex®) on the NHS, after the Scottish Medicines Consortium (SMC) approved it for use. Read the story here.
Continue Reading
For this week’s Article of the Week, we look at an article that describes a review of patient data from the Mayo Clinic.  The study sought to identify factors that could guide re-treatment in AL amyloidosis, with the goal of preventing organ progression.  Covering a period 1996-2014, the timeframe necessarily included a range of treatment approaches. ...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand